Medical Weight Loss & Aesthetics Clinic | $428K EBITDA | Repeat Rev

Asking PriceNot Disclosed

Cash Flow
Not Disclosed

EBITDA

Gross Revenue$3,150,000

InventoryNot Disclosed

FF&ENot Disclosed

listing imageSave

Medical Weight Loss & Aesthetics Clinic | $428K EBITDA | Repeat Rev


Asking PriceNot Disclosed

Cash Flow
Not Disclosed

EBITDA

Gross Revenue$3,150,000

InventoryNot Disclosed

FF&ENot Disclosed

Business Description
The Company is a founder-owned, cash-pay medical wellness and aesthetics clinic operating from a single leased facility in the Southeastern U.S. Founded in 2016, it offers a diversified mix of medical weight loss, hormone optimization, laboratory, IV therapy, peptides, men's health, and aesthetic services, entirely on a self-pay basis with no insurance or third-party reimbursement.
Care is delivered by an experienced team of employed nurse practitioners and registered nurses under a physician medical director, with ownership focused on administration rather than clinical delivery. The business serves 2,000+ active patients across a four-state region and has been debt-free since 2022, positioning it for a clean ownership transition.

▶ Recurring, Cash-Pay Revenue – 100% self-pay with no insurance or payor dependence; roughly 82% of active patients return each year and recurring patients generate about 98% of revenue, driving durable, relationship-based demand.
▶ Diversified Service Mix – Six complementary service lines led by medical weight loss (~40%) and hormone optimization/BHRT (~29%), serving 2,000+ active patients with no single-service or single-patient concentration.
▶ Debt-Free, Asset-Light Model – Debt-free since 2022, with low capital intensity (one leased clinic and modest equipment), a multi-year history of profitability, and clean cash-pay economics.
▶ High-Value Patient Economics – Patients spend an average of about $3,300 each over 2024-2025 (median about $2,000), and a high-value core, the 21% who spend $5,000+, drives 59% of revenue.

Revenue:
FY ’22: $1.48M
FY ’23: $3.27M
FY ‘24: $3.66M
FY ‘25: $3.15M
May ‘26 TTM: $2.60M

EBITDA:
FY ’22: $295K
FY ’23: $756K
FY ‘24: $723K
FY ‘25: $428K
May ‘26 TTM: $311K

Service Offerings:
Medical Weight Loss
Hormone/BHRT
IV Therapy
Peptides
Men’s Health
Aesthetics
Labs
About the Business
Employees
11 Full-time
Real Estate
Owned or Leased
Leased
Building Sq. Ft.
2,400
Rent
$7,208 per month
Lease Expiration
9/30/2030
About the Sale
Seller Motivation
Retirement
Listing Info
ID
2531853
Listing Views
Attached DocumentsAttachment Disclaimer

Teaser & NDA Project Fit for BizBuySell.pdf


Listing ID: 2531853 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.